Today's Pre-Market Stock Movers: BMY, ADBE, MSTR, AZN and More
Gapping up
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology(CLVS.US$ +11.3%, $Cardiff Oncology(CRDF.US$ +9%, $Immatics(IMTX.US$ +8.3%, $IDEAYA Biosciences(IDYA.US$ +8%, $Lyra Therapeutics(LYRA.US$ +5.7%, $POINT Biopharma(PNT.US$ +5.7%, $Edgewise Therapeutics(EWTX.US$ +4.7%, $Concert Pharmaceuticals(CNCE.US$ +3.6%, $Deciphera Pharmaceuticals(DCPH.US$ +3.2%, $Veracyte(VCYT.US$ +2.6%, $SpringWorks Therapeutics(SWTX.US$ +2.3%, $I-Mab(IMAB.US$ +2.3%, $Puma Biotechnology(PBYI.US$ +1.8%, $AstraZeneca(AZN.US$ +1.1%, $BeiGene(BGNE.US$+0.8%.
Other news:
$Spectrum Pharmaceuticals(SPPI.US$ +15.8% (receives FDA approval for R.OLVEDON injection; expects to launch product in Q4)
$Bristol-Myers Squibb(BMY.US$ +8.1% (receives FDA approval for Sotyktu)
$XL Fleet(XL.US$ +5.1% (completes transformational acquisition of Spruce Power)
$Enthusiast Gaming(EGLX.US$ +4.7% (signed a media sponsorship deal with Hulu + Live TV the premium streaming destination as the first official media sponsor of NFL Tuesday Night Gaming)
$Centessa Pharmaceuticals(CNTA.US$ +4.5% (Announces Non-Human Primate Pharmacokinetic and Safety Data for LB101)
$Fortuna Silver Mines(FSM.US$ +2.8% (extends gold mineralization at Sunbird and identifies new regional prospects at Sgula)
$ACADIA Pharmaceuticals(ACAD.US$ +2.6% (receives acceptance from FDA for NDA of Trofinetide)
$Occidental Petroleum(OXY.US$ +1.7% (Berkshire Hathaway discloses 26.8% stake up from 20.28% previously)
$Life Time(LTH.US$ +1.4% (closes on $200 million in sale-leaseback transactions)
$Chicken Soup for the Soul Entertainment(CSSE.US$ +1% (files for 7745453 share common stock offering by selling shareholders relates to warrants)
Gapping down
Select biotech/pharma names showing early weakness following ESMO:
$Apexigen(APGN.US$ -8%, $Lyell Immunopharma(LYEL.US$ -4.9%, $Amgen(AMGN.US$ -4%, $ImmunoGen(IMGN.US$ -2%
Other news:
$Relay Therapeutics(RLAY.US$ -8% (announces underwritten offering of $300 mln in common stock)
$Vroom(VRM.US$ -2.8% (files for $300 mln mixed securities shelf offering)
$MicroStrategy(MSTR.US$ -2.7% (enters into a Sales Agreement related to offering of up to $500 mln of common stock)
$Madison Square Garden Sports(MSGS.US$ -2.4% (President and CEO to step down at end of year; also names David Hopkinson as COOZ effective immediately)
$A10 Networks(ATEN.US$ -2.3% (purchased an aggregate of 3.5 mln of its shares from Summit)
$Allakos(ALLK.US$ -2.2% (Initiation of Phase 2b Clinical Trial of Subcutaneous Lirentelimab in Chronic Spontaneous Urticaria)
$Adobe(ADBE.US$ -1.1% (an analyst from Mizuho downgraded the rating stock to Neutral from Buy. Adobe reports earnings on Thursday)
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment